Ke Dan - Net Worth and Insider Trading

Ke Dan Net Worth

The estimated net worth of Ke Dan is at least $27 Million dollars as of 2025-04-10. Ke Dan is the Director of Jiangxi Fushine Pharmaceutical Co Ltd and owns about 3,523,000 shares of Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) stock worth over $27 Million. Details can be seen in Ke Dan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ke Dan has not made any transactions after 2022-01-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Ke Dan

To

Ke Dan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ke Dan owns 1 companies in total, including Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) .

Click here to see the complete history of Ke Dan’s form 4 insider trades.

Insider Ownership Summary of Ke Dan

Ticker Comapny Transaction Date Type of Owner
SZSE:300497 Jiangxi Fushine Pharmaceutical Co Ltd 2022-01-28 Director

Ke Dan Latest Holdings Summary

Ke Dan currently owns a total of 1 stock. Ke Dan owns 3,523,000 shares of Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) as of January 28, 2022, with a value of $27 Million.

Latest Holdings of Ke Dan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:300497 Jiangxi Fushine Pharmaceutical Co Ltd 2022-01-28 3,523,000 7.71 27,162,330

Holding Weightings of Ke Dan


Ke Dan Form 4 Trading Tracker

According to the SEC Form 4 filings, Ke Dan has made a total of 7 transactions in Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Jiangxi Fushine Pharmaceutical Co Ltd is the acquisition of 996,600 shares on January 28, 2022, which cost Ke Dan around $13 Million.

Insider Trading History of Ke Dan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ke Dan Trading Performance

GuruFocus tracks the stock performance after each of Ke Dan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ke Dan is 0.5%. GuruFocus also compares Ke Dan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ke Dan within 3 months outperforms 3 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ke Dan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ke Dan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.93 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 26.54 LIMIT LIMIT LIMIT LIMIT LIMIT

Ke Dan Ownership Network

Ownership Network List of Ke Dan

No Data

Ownership Network Relation of Ke Dan

Insider Network Chart

Ke Dan Owned Company Details

What does Jiangxi Fushine Pharmaceutical Co Ltd do?

Who are the key executives at Jiangxi Fushine Pharmaceutical Co Ltd?

Ke Dan is the Director of Jiangxi Fushine Pharmaceutical Co Ltd. Other key executives at Jiangxi Fushine Pharmaceutical Co Ltd include Executives Liu Ying , Secretary Dong peng yun , and Executives zhang xiang ming .

Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) Insider Trades Summary

Over the past 18 months, Ke Dan made no insider transaction in Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497). Other recent insider transactions involving Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) include a net purchase of 2,350,100 shares made by Bao Jian Hua , a net purchase of 47,600 shares made by yang guang , and a net purchase of 35,400 shares made by peng yun .

In summary, during the past 3 months, insiders sold 0 shares of Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497) were sold and 2,800,600 shares were bought by its insiders, resulting in a net purchase of 2,800,600 shares.

Jiangxi Fushine Pharmaceutical Co Ltd (SZSE:300497)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jiangxi Fushine Pharmaceutical Co Ltd Insider Transactions

No Available Data

Ke Dan Mailing Address

Above is the net worth, insider trading, and ownership report for Ke Dan. Currently GuruFocus does not have mailing address information for Ke Dan.